01/22/2026
Earlier this month, the Drug Enforcement Administration and U.S. Department of Health and Human Services (HHS) extended telemedicine flexibilities for prescribing Schedule II–V medications through December 31, 2026. This stability matters for access and continuity of care.
In my blog, I speak directly to the broader landscape telehealth sits within, including how it is shaping substance use disorder treatment and what technology developers need to understand about clinical realities, compliance expectations, and real-world implementation.
If you are building or scaling telehealth solutions in this space, let’s talk:
➡️ https://www.vantageclinicalconsulting.com/post/telehealth-in-substance-use-disorders-treatment-opportunities-advice-for-tech-developers
Jamelia Hand
By: Jamelia Hand MHS CADC CODPGina was one of the most exceptional counselors i’ve worked with. Her ability to connect with patients and guide them toward recovery was unmatched, and her dedication to their success made her indispensable at her organization. When I was brought in to help implement...